DISCLAIMER: Per the FDA, Thermography should not be used as the sole device to diagnose or screen for breast cancer or other conditions. Thermography should not be used in place of mammography and is only for use in addition to other diagnostic or screening devices. Use of thermography carries the risks of a delayed or missed diagnosis.

State-of-the-art Breast Thermography, also known as Digital Infrared Thermal Imaging or Medical Thermal Imaging is a screening tool for early breast cancer detection. It uses ultra-sensitive infrared cameras and sophisticated computer software to identify unusual changes in the temperature and blood vessels of the breasts. Breast Thermography is based on the principle that a cancer requires an infrastructure of abnormal blood vessels to supply the nutrients necessary for cancer's growth. These abnormal blood vessels are not under the control of the Autonomic Nervous System (ANS) and do not constrict in response to cold, whereas normal blood vessels supplying healthy tissues do. The Thermogram is able to visualize this infrastructure of abnormal blood vessels, by detecting the increased heat and blood flow surrounding abnormal tissues. This phenomenon is what increases clinical Thermography's sensitivity (accuracy) and specificity (ability to rule out false positives). Mammography, in contrast, has a high rate of false positives necessitating further invasive testing. However, always remember that mammography is considered the first line of defense in diagnosing breast cancer and thermography should only be used as an adjunct procedure to Mammography.


  • In 1982, the FDA approved Breast Thermography as an adjunctive diagnostic breast cancer screening procedure.
  • Breast Thermography has undergone extensive research since the late 1950’s.
  • Over 800 peer-reviewed studies on Breast Thermography exist in the index-medicus literature.
  • In this database, well over 300,000 women have been included as study participants.
  • The numbers of participants in many studies are very large: 10K, 37K, 60K, 85K.
  • Some of these studies have followed patients up to 12 years.
  • Strict standardized interpretation protocols have been established for over 15 years.
  • Breast Thermography has a reported high sensitivity and specificity, based on numerous studies of types of breast cancers.
  • An abnormal thermogram is 10 times more significant as a future risk indicator for breast cancer than a first order family history of the disease.
  • A persistent abnormal thermogram carries with it a 22 times greater risk of future breast cancer.
  • An abnormal infrared image is an important marker of high risk for developing breast cancer.
  • Breast Thermography has the ability to detect signs that a cancer may be forming and can be used as an adjunct procedure to mammography.
  • Extensive clinical trials have shown that Breast Thermography significantly augments the long-term survival rates of its recipients by as much as 61%.
  • When used as part of a multimodal approach (clinical examination + mammography + thermography), 95% of early stage cancers will be detected.

Copyright 2004-2018 © Early Cancer Detection.com All Rights Reserved
Site designed, developed and maintained by Digital Bliss LLC.